POZEN Inc (NASDAQ:POZN)
| 4.96 Data as of May 20 |  +0.06 / +1.22%Today’s Change | 4.26 Today|||52-Week Range 7.55 | -1.00% Year-to-Date |
Latest POZN News | Press Releases
No recent news for POZEN Inc.
Today’s Trading
| Previous close | 4.90 |
| Today’s open | 4.90 |
| Day’s range | -- - -- |
| Volume | 122,269 |
| Average volume (3 months) | 271,074 |
| Market cap | $150.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -160.00% |
| Earnings growth (this year) | +3.57% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -93.85% |
| P/E ratio | NM |
| Price/Sales | 28.18 |
| Price/Book | 1.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZIOPZIOPHARM Oncology In... | +0.13 | +7.78% |
| TGTXTG Therapeutics Inc | +0.30 | +5.56% |
| AVEOAveo Pharmaceuticals... | -0.12 | -3.99% |
| HZNPHorizon Pharma Inc | -0.01 | -0.42% |
Data as of 4:00pm ET, 05/20/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $5.3M |
| Annual profit (last year) | -$25.3M |
| Net profit margin | -472.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer John R. Plachetka, PhD |
Chief Financial Officer & SVP-Administration William L. Hodges, CPA |
Corporate headquarters Chapel Hill, North Carolina |
Forecasts
